Literature DB >> 6538270

HLA-linked complement markers in Alzheimer's and Parkinson's disease: C4 variant (C4B2) a possible marker for senile dementia of the Alzheimer type.

C Nerl, R Mayeux, G J O'Neill.   

Abstract

We determined the gene frequencies for the alleles of the HLA-linked complement markers C2, properdin factor B (BF), C4A (Rodgers) and C4B (Chido), and the red cell enzyme glyoxalase-I in 38 unrelated patients with senile dementia of the Alzheimer type, 42 patients with idiopathic Parkinson's disease, and 59 unaffected, aged-matched control blood donors. In senile dementia of the Alzheimer type and in Parkinson's disease, no significant difference was found in the gene frequencies of alleles at either the BF, C2, or GLO-I locus compared with those of age-matched controls. In senile dementia of the Alzheimer type, a striking increase in the frequency of the rare C4B locus allele, C4*B2, was apparent, resulting in the high relative risk of RR = 8.8 (p less than 0.0001) for this disorder.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6538270     DOI: 10.1212/wnl.34.3.310

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Complement allotypes in familial and sporadic Alzheimer's disease.

Authors:  P K Panegyres; R L Dawkins
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

2.  Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease.

Authors:  Gyungah R Jun; Yang You; Congcong Zhu; Gaoyuan Meng; Jaeyoon Chung; Rebecca Panitch; Junming Hu; Weiming Xia; David A Bennett; Tatiana M Foroud; Li-San Wang; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Gerard D Schellenberg; Rhoda Au; Kathryn L Lunetta; Tsuneya Ikezu; Thor D Stein; Lindsay A Farrer
Journal:  Alzheimers Dement       Date:  2022-02-09       Impact factor: 16.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.